Navigation Links
Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
Date:10/14/2008

as every 15-30 minutes in more severe cases. In addition, Durezol does not contain benzalkonium chloride (BAK), a common ocular preservative known to cause corneal toxicity with long-term use. This is especially important for patients with uveitis, which is a chronic disease. A strong steroid like Durezol will be a very valuable tool for ophthalmologists everywhere, allow patients to have an easier dosing regimen, and will most likely become the new standard of care for treating uveitis."

In addition to reducing mean cell grade, a greater percentage of patients receiving Durezol had an AC cell grade of 0 (less than or equal to 1 cell) than did the Pred Forte group at Day 14 (69% vs 62%, respectively). This trend continued through Day 42.

Ocular discomfort and pain is a debilitating symptom of uveitis. In this study, pain was assessed using a Visual Analog Scale. Durezol demonstrated a numerical advantage in pain reduction from baseline over Pred Forte at every time point in the study. As early as Day 3, the Durezol group had a reduction in mean pain score of 58% vs 51% in the Pred Forte group. At Day 7, these were 71% and 64%, respectively.

Durezol was also very effective in reducing the symptoms of anterior ocular inflammation (pain/ocular discomfort, photophobia, blurred vision, and lacrimation). The Durezol group achieved a mean reduction in total symptom score of 76% vs 71% for Pred Forte at Day 14. This numerical difference was maintained through Day 42 with the Durezol group reducing the total symptom score by 86% vs 76% for the Pred Forte group.

The total sign score was also reduced to a greater degree in the Durezol group when compared to the Pred Forte group: 6.5 vs 6.1 at Day 14, respectively. Total sign score included the sums of posterior synechiae, hypopyon, limbal injection, peripheral anterior synechiae, AC flare, AC cell and keratic precipitate grades. The numerical advantage of Durezol over Pred Forte in total sign score
'/>"/>

SOURCE Sirion Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sirion Therapeutics Announces Positive Phase III Results for Difluprednate
2. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... , 6. März 2015  Unfors ... Röntgenstrahlen, feierte auf dem European Congress of ... , Österreich, die 1.000. Installation seines Systems ... Logo - http://photos.prnewswire.com/prnh/20150304/179432LOGO ... der in Echtzeit Informationen über die Dosis ...
(Date:3/6/2015)... 6, 2015  AbbVie (NYSE: ABBV ) ... on Thursday, March 12, 2015. Richard A. Gonzalez ... a question and answer session at 8:30 a.m. Central ... presentation will be accessible through AbbVie,s Investor Relations Web ... the session will be available later that day. ...
(Date:3/6/2015)... , March 6, 2015   Veracyte, Inc. ... demonstrating that diagnostic tests that use increasing numbers of ... reduce the specificity of test results, leading to an ... erroneously diagnosed as cancerous. In addition, these new data ... the malignancies leading to "false negatives." The data were ...
Breaking Medicine Technology:Unfors RaySafe, ein Unternehmen von Fluke Biomedical, feiert 1.000. Installation seines Systems zur Echtzeit-Strahlendosimetrie 2Unfors RaySafe, ein Unternehmen von Fluke Biomedical, feiert 1.000. Installation seines Systems zur Echtzeit-Strahlendosimetrie 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 2Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 4Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 5Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 6
... Inc. (NYSE AMEX: ULU) today announced that it ... ended September 30, 2011 financial results and to provide a ... a.m. Eastern Time. To participate in the conference ... 429-1388 (access code 23823#) five to ten minutes prior to ...
... FRANCISCO, Nov. 11, 2011 Boston Scientific Corporation ... the EVOLVE First Human Use trial demonstrating the ... to the PROMUS Element™ Everolimus-Eluting Stent System in ...  The trial provided 30-day clinical and six-month angiographic ...
Cached Medicine Technology:ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2011 and to Provide a Business Update 2Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 2Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 3Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 4Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 5
(Date:3/6/2015)... March 06, 2015 Further solidifying their ... Medical Doctor Associates announced today that the company has ... winning the Best of Staffing Talent Award five years ... Best of Staffing Talent Diamond winners are proven industry ... to them by the individuals they have helped find ...
(Date:3/6/2015)... 2015 Johnson & Johnson and Ethicon ... March 5, 2015 in Superior Court in the State ... a jury of 12 awarded Mrs. Perry $700,000 in ... with an Ethicon TVT Abbrevo plastic sling for stress ... women also awarded $5 million in punitive damages. , ...
(Date:3/6/2015)... Covington, La (PRWEB) March 06, 2015 ... reduced function despite medical therapy. If you (or someone ... due to knee osteoarthritis, you may be interested in ... with Covington Orthopedic announced today that he is one ... from Cytori Therapeutics to begin enrolling subjects as part ...
(Date:3/6/2015)... March 06, 2015 Truly Nolen, the ... to announce the grand opening of their first independently-owned ... area down to the Fort Mill – Rock Hill, ... February 27th, 2015 at their new location. ... years of collective experience in the pest control industry. ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Yisrayl Hawkins, ... Abilene, Texas, has released a new publication explaining how ... , The article titled “Microorganisms Do Much ... explaining how tiny microorganisms were created and designed to ... aware of some of the functions of these micro-kingdom, ...
Breaking Medicine News(10 mins):Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 3Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:First Truly Nolen Franchise Opening in North Carolina 2Health News:Yisrayl Hawkins Tells Scientists Exactly What Makes Life Function Properly in New Publication 2
... , , , ... California Cardiothoracic Surgery Center specializes in cardiothoracic surgery ... not seem like serious symptoms. In fact, most people brush off ... simple symptoms can be indications of the need for ...
... , , , , ... affects 40 percent of the world,s population, often resulting in patches of ... KP is most prevalent in the teenage years but may continue throughout ... , Dr. Alan B. Fleischer, professor and chair of the ...
... role, study says , MONDAY, July 27 (HealthDay News) -- ... blood pressure, may experience a "silent stroke" and won,t even ... truly silent, because they have been linked to memory and ... of dementia," study author Dr. Perminder Sachdev, a neuropsychiatry professor ...
... , , , ... holidays, and job searching, along with many other activities and errands, it ... simplest option, and at a few dollars a day, it may not ... eating out every month, hitting tight budgets. According to Fast Food Nation, ...
... (PHILADELPHIA) Smoking has once again been implicated in ... way of cigarette smoking may increase the likelihood that ... from the Kimmel Cancer Center at Jefferson. Their study ... Surgery . The culprit behind the increased ...
... , , MINNEAPOLIS and ... Health recently designated Children,s Hospitals and Clinics of Minnesota,s two ... Minnesota has the sixth busiest pediatric emergency department in the ... around 450 trauma cases each year. Children,s voluntarily participated ...
Cached Medicine News:Health News:Southern California Surgical Center (heart411.com) Specializes in Mitral Valve Replacement 2Health News:What Is Keratosis Pilaris (KP)? 2Health News:People Over 60 at Risk for 'Silent Stroke' 2Health News:As Good As a Deli, For the Price of Making It At Home 2Health News:Smoking increases potential for metastatic pancreatic cancer 2Health News:Children's Hospitals and Clinics of Minnesota Receive Level III Trauma Designation 2Health News:Children's Hospitals and Clinics of Minnesota Receive Level III Trauma Designation 3
... 6-inch Electro-Dermatome. This is the only ... six inch graft can cover most adult ... seams. This dermatome has been designed to ... is decreased considerably and the handle temperature ...
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates....
BD Visitec IOL Manipulator (Fenzl), blunt tip angled 45, 12.0 mm from end, fits 0.20 mm diameter holes and larger (3/bx, 1 bx/ca). For positioning intraocular lenses. Sure grip handles hand ridge ind...
Hunkeler lens manipulator, angled. Also available in titanium....
Medicine Products: